ARCHIVES

NIH And E.I. Dupont Sign OncoMouse Agreement.

This article is from The Cancer Letter archive.

Vol. 26 No. 04 | January 28, 2000

Download PDF Visit The Full Archive

Related Articles

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

December 31, 2010

Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates

April 16, 1999

In Brief: Maryland Wins Center Planning Grant; CRC Receives $5 Million To Endow Chair

December 10, 1999

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

Broder Not Satisfied With Mortality STATS On Three Major Cancers

September 20, 1991